GlobalData on MSN6h
Vyne doses first participant in Phase Ib plaque psoriasis treatment trialVyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for ...
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback